Avertix Medical
Medical Devices, 2210 Faraday Ave, Carlsbad, California, 92008, United States, 51-200 Employees
Phone Number: +12*********
Who is AVERTIX MEDICAL
Avertix is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease through innovation, clinical science, and collaboration. Wit...
Read More
-
Headquarters: 2210 Faraday Ave, Carlsbad, California, 92008, United States
-
Date Founded: 2001
-
Employees: 51-200
-
Revenue: $100 Million to $250 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 5047
|
NAICS Code: 423450 |
Show More
Does something look wrong? Fix it. | View contact records from AVERTIX MEDICAL
Avertix Medical Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Avertix Medical
Answer: Avertix Medical's headquarters are located at 2210 Faraday Ave, Carlsbad, California, 92008, United States
Answer: Avertix Medical's phone number is +12*********
Answer: Avertix Medical's official website is https://avertix.com
Answer: Avertix Medical's revenue is $100 Million to $250 Million
Answer: Avertix Medical's SIC: 5047
Answer: Avertix Medical's NAICS: 423450
Answer: Avertix Medical has 51-200 employees
Answer: Avertix Medical is in Medical Devices
Answer: Avertix Medical contact info: Phone number: +12********* Website: https://avertix.com
Answer: Avertix is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease through innovation, clinical science, and collaboration. With FDA-approved labeling indicating the Guardian System is safe and effective, were dedicated to providing physicians, health systems, and allied health professionals with the Avertix Guardian to help advance the standard of patient care. Avertixs GuardianTM is the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks. Delays in treatment contribute to the high level of mortality and morbidity from heart attacks. Symptoms (such as chest pain) are a poor predictor of ACS events with less than 20% of patients presenting to the emergency room actually having a true positive ACS event and more than one-third of heart attacks having atypical or no symptoms.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month